Status: Recruiting
Botulinum Toxin Therapy in Hidradenitis Suppurativa
This study will build on data from mice and humans implicating TRPV1 nociceptors in the pathogenesis of the type-17 chronic inflammatory skin disease Hidradenitis Suppurativa (HS). In this study, the investigators will test the hypothesis that inhibiting neuropeptide activity with botulinum toxin reduces pathogenic inflammation.
Participants needed: 20
Trial details
Age: 18-75Biological sex: AllType: ObservationalSponsor: University of Massachusetts, WorcesterUpdated: Aug 7, 2026Locations: 1
Eligibility criteria
Adults between ages 18 and 75 years with established diagnosis of hidradenitis s... [+9]